Barrett, John A <br/><br/>
Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.  [electronic resource] 

 -  Cancer biotherapy & radiopharmaceuticals  Jun 2010 
 - 299-308 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1557-8852 
<br/><br/><label>Standard No.: </label>10.1089/cbr.2009.0695  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3-Iodobenzylguanidine--analogs & derivatives<br/>Animal Structures--metabolism<br/>Animals<br/>Blood Pressure--drug effects<br/>Bone Marrow--metabolism<br/>Bradycardia--chemically induced<br/>Dogs<br/>Electrocardiography--drug effects<br/>Female<br/>Heart--drug effects<br/>Heart Rate--drug effects<br/>Humans<br/>Iodine Radioisotopes--chemistry<br/>Isotope Labeling--methods<br/>Male<br/>Mice<br/>Mice, Nude<br/>Myocardium--metabolism<br/>Neuroblastoma--pathology<br/>Radiopharmaceuticals--chemical synthesis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tissue Distribution<br/>Xenograft Model Antitumor Assays